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An unexpected and large outbreak of Puumala virus 
infection in Sweden resulted in 313 nephropathia epidemi-
ca patients/100,000 persons in Västerbotten County during 
2007. An increase in the rodent population, milder weather, 
and less snow cover probably contributed to the outbreak.
M
embers of the genus Hantavirus (family Bunyaviri-
dae) are rodent-borne pathogens, and virus is trans-
mitted to humans by inhalation of infected rodent excreta 
(1). In Sweden, Finland, Norway, Russia, and parts of cen-
tral Europe, Puumala virus (PUUV) is endemic in bank 
voles (Myodes glareolus). PUUV infection in humans cause 
nephropathia epidemica (NE), a mild form of hemorrhagic 
fever with renal syndrome (HFRS). In Sweden ≈90% of all 
NE cases are found in the 4 northernmost counties. Väster-
botten County (Figure 1) has the highest incidence of hu-
man hantavirus infection in Sweden and probably one of 
the highest worldwide. Historically, the incidence rate is 20 
per 100,000 persons per year (2), but the true incidence is 
considered to be 7–8 times higher (3). 
There is a 3–4-year periodicity in the number of NE 
cases that is linked to the bank vole population dynamics 
in northern Sweden (2). After inhaling infectious aerosols 
originating from rodent saliva, urine, or feces, the patient 
has a 1–5-week incubation period before onset of disease 
symptoms. The most common NE symptoms are fever, 
headache, nausea, abdominal and back pain, vomiting, 
myalgia, and visual disturbance. One third of the patients 
have mostly mild hemorrhagic manifestations (4,5). Renal 
failure is typical with initial oliguria during the acute phase 
and polyuria in the convalescence phase. Dialysis is some-
times needed and <0.5% of NE cases are fatal. There is no 
effective treatment or available vaccine.
The Study
The local University Hospital of Umeå is the refer-
ence center for diagnosis of NE serving the 4 northernmost 
counties of Sweden, and many patients with NE are hospi-
talized here. In 2007, a sudden and large outbreak of hanta-
virus infections occurred in northern Sweden. The outbreak 
peaked in January 2007 (Figure 1) with many NE patients 
who had a considerable effect on public health services. 
The NE outbreak continued in the following months, but 
with fewer cases than in early 2007 (Figure 1). 
For NE diagnosis, we used an immunoﬂ  uorescence as-
say to detect PUUV-reactive immunoglobulin (Ig) M and 
IgG antibodies in serum of all patients with clinically sus-
pected NE (6). A real-time reverse transcription–PCR (6) 
was used to obtain an ampliﬁ  cation product from 1 patient 
sample. This product was sequenced and the S-segment se-
quence obtained (GenBank accession no. EU177630) was 
highly homologous to those of other rodent PUUV isolates 
from the area.
NE is a reportable disease under the Swedish Com-
municable Diseases Act. The outbreak peaked during the 
ﬁ  rst 3 months of 2007; 972 cases were recorded in Sweden 
and 474 cases in Västerbotten County. NE patients mostly 
showed classic HFRS symptoms and mild to severe disease 
requiring hospitalization and occasionally intensive care. 
Accordingly, as many as 30% of the patients whose condi-
tions had been diagnosed as NE were hospitalized, and 2 
known deaths (case-fatality rate 0.25%) in the 2 northern-
most counties in Sweden were recorded during the ﬁ  rst 3 
months of 2007. No patient had to continue dialysis after 
the acute phase of the disease. 
We detected PUUV RNA in the milk of 2 breastfeeding 
women with a diagnosis of NE. Their children did not show 
any clinical symptoms of NE. However, we did not have ac-
cess to samples to analyze whether the children had asymp-
tomatic infections. Three pregnant women also had received 
a diagnosis of NE, but no clinical evidence of transmission 
from mother to child was reported. Analyses of the placentas 
did not detect any PUUV RNA. Only maternal IgG antibod-
ies to PUUV were found in blood from umbilical cords. One 
woman miscarried after 12 weeks of pregnancy 3 weeks be-
fore showing symptoms of clinical NE, and death of the fetus 
may have been caused by viremia during the incubation peri-
od. During the peak of the outbreak (December 2006–March 
2007), 488 cases occurred in Västerbotten County, and, as 
expected, more men (58%, 281/488) than women (42%, 
207/488) had NE; most cases (72%) were among persons 
35–74 years of age (Table).
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Figure 1. Monthly incidence of nephropathia epidemica (NE) 
in Sweden and Västerbotten County, Sweden, January 1997–
September 2007.Outbreak of Puumala Virus Infection, Sweden
The incidence of NE in Västerbotten County was 313 
diagnosed cases/100,000 persons in 2007 compared with 
73/100,000 in 1999, 38/100,000 in 2002, and 61/100,000 in 
2005 (Figure 1). The number of NE cases usually depends 
on the size of the vole population, which peaks every third 
to fourth year (2,7). An increase in the bank vole popula-
tion was reported in northern Sweden in the fall of 2006, 
with a trap index of 7.64. This index is similar to those of 
2 NE peaks in the fall of 1998–1999 and 2004–2005 when 
trap indices were ≈8 (8). Trapping indices represents the 
number of voles captured per 100 trapping nights, a reﬂ  ec-
tion of the relative population size on each sampling occa-
sion (9). Thus, the bank vole population was high, but not 
more than in previous peak years and could not explain the 
high number of NE cases in 2007.
We considered other possible factors inﬂ  uencing hanta-
virus transmission to humans. One factor is increased expo-
sure of humans to infected rodent excreta. We had received 
several reports from inhabitants in areas where bank voles 
normally live that more bank voles were found in traps in-
side houses than usual. When we investigated the weather 
conditions during this period, December 2006 was excep-
tional with respect to the mild weather with no or little snow 
and hard ice cover in the coastal area of northern Sweden. In 
Västerbotten County, the average temperature in December 
was 6.0°C–9.0°C warmer than normal (normally the average 
temperature in Västerbotten County varies by –4°C along the 
coast and –13°C in the mountains) The average temperature 
in Sweden was 4.5°C–9.5°C warmer than normal in Decem-
ber 2006 (Figure 2). The snow cover during winter is impor-
tant for bank vole survival because bank voles have access 
to food below the snow and hide from predators and the cold 
(10). During 2 previous NE peak periods (2001–2002 and 
2004–2005), the ground was already covered with snow in 
early winter (Figure 2). For these reasons, during December 
2006, when the ground had no snow cover for 25 of 31 days 
(Figure 2), bank voles may have sought refuge in barns and 
houses and other buildings, thereby increasing the exposure 
for the human population at risk. A concurrent epizootic may 
have occurred among bank voles, which resulted in larger 
numbers of infectious animals, as shown in previous rodent 
studies (11,12). However, we did not have access to rodents 
during this period and this hypothesis needs to be studied.
Conclusions
This report shows how a zoonotic disease can sudden-
ly result in an unexpected and large human outbreak. Pres-
ently, the numbers of NE cases in northern Sweden are still 
unusually high. Data indicate that the bank vole population 
during the fall of 2007 increased to an even higher level 
and a new outbreak is forecasted (8). However, the size of 
the rodent population is not the only factor that determines 
the size of a hantavirus epidemic. As shown in this report, 
climate factors may have contributed to the recent large 
outbreak in northern Sweden.
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Table. Nephropathia epidemica cases in Västerbotten County, 
Sweden, December 1, 2006–March 31, 2007 
Age group, y  No. (%) cases 
<1–4 1 (0.20)
5–14 16 (3.3)
15–24 34 (7.0)
25–34 48 (9.8)
35–44 82 (17)
45–54 89 (18)
55–64 103 (21) 
65–74 78 (16)
75–84 32 (6.6)
85–94 5 (1.0)
Total 488 (100) 
Figure 2. Climate conditions, December 1998–2006, in the 
nephropathia epidemica outbreak area of Västerbotten County, 
Sweden. A) Number of days with a snow cover. B) Average 
temperature. Snow cover was deﬁ   ned as a snow depth >0 cm. 
Measurements were made in locations ≈30 km from the coast. Data 
were obtained from the Swedish Meteorological and Hydrological 
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